Research ArticleRheumatoid Arthritis

Rheumatoid Arthritis Magnetic Resonance Imaging Score Predicts Therapy Response: Results of the German ArthroMark Cohort

Philipp Sewerin, Lien Le, Stefan Vordenbäumen, Christoph Schleich, Ruben Sengewein, Ralph Brinks, Georg Pongratz, Ellen Bleck, Juliane Lesch, Ulrich Mansmann, Matthias Schneider and Benedikt Ostendorf
The Journal of Rheumatology June 2018, 45 (6) 753-759; DOI: https://doi.org/10.3899/jrheum.170797

REFERENCES

  1. 1.↵
    1. Smolen JS,
    2. Aletaha D,
    3. Bijlsma JW,
    4. Breedveld FC,
    5. Boumpas D,
    6. Burmester G,
    7. et al.
    Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631–7.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Mierau M,
    2. Schoels M,
    3. Gonda G,
    4. Fuchs J,
    5. Aletaha D,
    6. Smolen JS
    . Assessing remission in clinical practice. Rheumatology 2007;46:975–9.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Yazici H,
    2. Ozguler Y,
    3. Hatemi G,
    4. Yazici Y
    . Recommendations in the American College of Rheumatology guideline for the treatment of rheumatoid arthritis related to the use of biologic agents in patients with a history of cancer need reconsideration: comment on the article by Singh et al. Arthritis Rheumatol 2016;68:1315–6.
    OpenUrl
  4. 4.↵
    1. Colebatch AN,
    2. Edwards CJ,
    3. Østergaard M,
    4. van der Heijde D,
    5. Balint PV,
    6. D’Agostino MA,
    7. et al.
    EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 2013;72:804–14.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Emery P,
    2. McInnes IB,
    3. van Vollenhoven R,
    4. Kraan MC
    . Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis. Rheumatology 2008;47:392–8.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Grigor C,
    2. Capell H,
    3. Stirling A,
    4. McMahon AD,
    5. Lock P,
    6. Vallance R,
    7. et al.
    Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263–9.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. De Cock D,
    2. Vanderschueren G,
    3. Meyfroidt S,
    4. Joly J,
    5. Van der Elst K,
    6. Westhovens R,
    7. et al.
    The performance of matrices in daily clinical practice to predict rapid radiologic progression in patients with early RA. Semin Arthritis Rheum 2014;43:627–31.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Aletaha D,
    2. Neogi T,
    3. Silman AJ,
    4. Funovits J,
    5. Felson DT,
    6. Bingham CO,
    7. et al.
    2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580–8.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Schleich C,
    2. Müller-Lutz A,
    3. Sewerin P,
    4. Ostendorf B,
    5. Buchbender C,
    6. Schneider M,
    7. et al.
    Intra-individual assessment of inflammatory severity and cartilage composition of finger joints in rheumatoid arthritis. Skeletal Radiol 2015;44:513–8.
    OpenUrl
  10. 10.↵
    1. Sewerin P,
    2. Buchbender C,
    3. Vordenbäumen S,
    4. Scherer A,
    5. Miese F,
    6. Brinks R,
    7. et al.
    Advantages of a combined rheumatoid arthritis magnetic resonance imaging score (RAMRIS) for hand and feet: Does the RAMRIS of the hand alone underestimate disease activity and progression? BMC Musculoskelet Disord 2014;15:104.
    OpenUrl
  11. 11.↵
    1. Møller-Bisgaard S,
    2. Hørslev-Petersen K,
    3. Ejbjerg BJ,
    4. Boesen M,
    5. Hetland ML,
    6. Christensen R,
    7. et al.
    Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial. Trials 2015;16:178.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. McQueen FM,
    2. Chan E
    . Insights into rheumatoid arthritis from use of MRI. Curr Rheumatol Rep 2014;16:388.
    OpenUrl
  13. 13.↵
    1. McQueen FM
    . Imaging in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2013;27:499–522.
    OpenUrlCrossRef
  14. 14.↵
    1. Sewerin P,
    2. Ostendorf B
    . [New imaging procedures in rheumatology: from bench to bedside.] [Article in German] Dtsch Med Wochenschr 2014;139:1835–41.
    OpenUrl
  15. 15.↵
    1. Vordenbäumen S,
    2. Sewerin P,
    3. Lögters T,
    4. Miese F,
    5. Schleich C,
    6. Bleck E,
    7. et al.
    Inflammation and vascularisation markers of arthroscopically-guided finger joint synovial biospies reflect global disease activity in rheumatoid arthritis. Clin Exp Rheumatol 2014;32:117–20.
    OpenUrl
  16. 16.↵
    1. McQueen FM,
    2. Ostendorf B
    . What is MRI bone oedema in rheumatoid arthritis and why does it matter? Arthritis Res Ther 2006;8:222.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Xu S,
    2. Wang Y,
    3. Lu J,
    4. Xu J
    . Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. Rheumatol Int 2012;32:3397–403.
    OpenUrlPubMed
  18. 18.↵
    1. Nielsen AR,
    2. Plomgaard P,
    3. Krabbe KS,
    4. Johansen JS,
    5. Pedersen BK
    . IL-6, but not TNF-α, increases plasma YKL-40 in human subjects. Cytokine 2011;55:152–5.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Alizai H,
    2. Virayavanich W,
    3. Joseph GB,
    4. Nardo L,
    5. Liu F,
    6. Liebl H,
    7. et al.
    Cartilage lesion score: comparison of a quantitative assessment score with established semiquantitative MR scoring systems. Radiology 2014;271:479–87.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Syversen SW,
    2. Goll GL,
    3. van der Heijde D,
    4. Landewé R,
    5. Gaarder PI,
    6. Odegård S,
    7. et al.
    Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression. J Rheumatol 2009;36:266–72.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Prevoo ML,
    2. van ‘t Hof MA,
    3. Kuper HH,
    4. van Leeuwen MA,
    5. van de Putte LB,
    6. van Riel PL
    . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Felson DT,
    2. Smolen JS,
    3. Wells G,
    4. Zhang B,
    5. van Tuyl Lilian HD,
    6. Funovits J,
    7. et al.
    American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011;63:573–86.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Fransen J,
    2. Creemers MC,
    3. Van Riel PL
    . Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology 2004;43:1252–5.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Espinoza F,
    2. Fabre S,
    3. Pers YM
    . Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implications. Ther Adv Musculoskelet Dis 2016;8:107–18.
    OpenUrlCrossRef
  25. 25.↵
    1. Ma MH,
    2. Scott IC,
    3. Kingsley GH,
    4. Scott DL
    . Remission in early rheumatoid arthritis. J Rheumatol 2010;37:1444–53.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Baker JF,
    2. Ostergaard M,
    3. Emery P,
    4. Hsia EC,
    5. Lu J,
    6. Baker DG,
    7. et al.
    Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial. Ann Rheum Dis 2014;73:1968–74.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Gandjbakhch F,
    2. Haavardsholm EA,
    3. Conaghan PG,
    4. Ejbjerg B,
    5. Foltz V,
    6. Brown AK,
    7. et al.
    Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity. J Rheumatol 2014;41:398–406.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Østergaard M,
    2. Peterfy C,
    3. Conaghan P,
    4. McQueen F,
    5. Bird P,
    6. Ejbjerg B,
    7. et al.
    OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 2003;30:1385–6.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Khosla S
    . Minireview: the OPG/RANKL/RANK system. Endocrinology 2001;142:5050–5.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section

Keywords

MAGNETIC RESONANCE IMAGING
RHEUMATOID ARTHRITIS
PREDICTION
REMISSION
THERAPY RESPONSE

Keywords